Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €77.10 EUR
Change Today +2.32 / 3.10%
Volume 608.7K
As of 3:55 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rolf A. Classon

Member of The Supervisory Board and Vice Chairman of Regulatory & Reimbursement Assessment Committee, Fresenius Medical Care AG & Co. KGAA
AgeTotal Calculated CompensationThis person is connected to 47 board members in 9 different organizations across 18 different industries.

See Board Relationships
69--

Background*

Mr. Rolf A. Classon served as a Member of the Portfolio Services Group and Operating Partner of Growth Buyout Fund at Health Evolution Partners. He served as the Chief Executive Officer and President of Bayer Healthcare, LLC at Bayer AG. Mr. Classon served as the Interim Chief Executive Officer and President of Hill-Rom Holdings, Inc. from May 11, 2005 to March 20, 2006. He was the interim President and Chief Executive Officer of Hillenbrand Industries. He served as ...

Read Full Background

Corporate Headquarters*

Else-Kröner Strasse 1
Bad Homburg, Hessen 61352

Germany

Phone: 49 6172 6090
Fax: 49 6172 609 2301

Board Members Memberships*

Former Chairman and Chairman of Nominating & Corporate Governance Committee
Chairman of the Board
Chairman of the Board
Non-Executive Chairperson
Chairman
1997-2011
Former Director, Chairman of Compensation Committee, Member of Finance & Audit Committee and Member of Executive Committee
2002-Present
Chairman of the Board, Chairman of Mergers & Acquisitions Committee, Vice Chairman of Nominating/Corporate Governance Committee and Member of Compensation & Management Development Committee
2004-2007
Former Independent Director and Chairman of Nominating & Corporate Governance Committee
2004-N/A
Former Chairman
2004-2015
Former Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2005-2010
Former Outside Director, Member of Governance & Public Policy Committee and Member of Technology Committee
2006-2009
Former Independent Director, Member of Nominating & Corporate Governance Committee and Member of Strategic Alternatives Committee
2007-N/A
Independent Non Executive Director, Member of Audit Committee and Member of Compensation Committee
2009-Present
Chairman and Chairman of Nomination & Governance Committee
2011-Present
Chairman and Member of Nominating Committee
2011-2011
Former Chairman of the Board
2012-2014
Former Director and Member of Audit Committee
2014-Present
Director
2014-Present
Director and Member of Audit Committee

Education*

Unknown/Other Education
Göteborgs universitet
Master's Degree
Göteborgs universitet
MBA
Göteborgs universitet
Unknown/Other Education
Technical University in Gothenburg Sweden

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FME:GR €77.10 EUR +2.32

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Andrew Philip Witty Chief Executive Officer, Executive Director and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE AG &, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.